2016
DOI: 10.17116/hirurgia2016537-44
|View full text |Cite
|
Sign up to set email alerts
|

Total mesorectal excision in rectal cancer management: laparoscopic or transanal?

Abstract: Preliminary data show comparable early outcomes after transanal and laparoscopic techniques. Laparotomy and associated compications are avoided in case of transanal extraction of specimen. Further researches are necessary to study functional and long-term results.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 20 publications
0
3
0
Order By: Relevance
“…Four studies [ 38 – 41 ] published as thesis and not in peer-reviewed journals were excluded. One study [ 42 ] with a printing error but was repaired and one study [ 43 ] in Russian were excluded. For four studies with more than two arms, we removed the open surgery group from two studies [ 19 , 27 ] and the laparoscopic surgery plus a traditional nursing group [ 30 ] or combined two NOSES-type arms into one [ 32 ].…”
Section: Resultsmentioning
confidence: 99%
“…Four studies [ 38 – 41 ] published as thesis and not in peer-reviewed journals were excluded. One study [ 42 ] with a printing error but was repaired and one study [ 43 ] in Russian were excluded. For four studies with more than two arms, we removed the open surgery group from two studies [ 19 , 27 ] and the laparoscopic surgery plus a traditional nursing group [ 30 ] or combined two NOSES-type arms into one [ 32 ].…”
Section: Resultsmentioning
confidence: 99%
“…The standard neoadjuvant therapy in most parts of the world, including North America and Western Europe, is long-course CRT consists of 50-50. 4 Gy radiotherapy (RT) in 5-5.5 weeks concurrently with intravenous 5-fluorouracil (5FU) or oral capecitabine [7][8][9][10]. Since the hallmark study by Sauer et al [6] there have been many efforts to improve neoadjuvant treatment outcomes to enhance the pathological complete response (pCR) and reduce local and distant recurrence.…”
Section: Introductionmentioning
confidence: 99%
“…Currently, the mainstay treatment for locally advanced rectal cancer (LARC) is total mesorectal excision (TME), either open or using minimally invasive methods like robotic or laparoscopic surgery [ 3 ]. Compared to the colon, the cancers of the rectum harbor distinct considerations, including the limited space to obtain sufficient margins and to dissect lateral lymph node in the true pelvis [ 3 , 4 ]. Due to these considerations, adjuvant chemoradiation (CRT) has increased the survival of rectal cancer patients and decreased the likelihood of local recurrence (LR).…”
Section: Introductionmentioning
confidence: 99%